开发富含紧密黏附素的外膜囊泡(OMVs)疫苗以控制肠出血性大肠杆菌的肠道携带
本研究开发了基于外膜囊泡(OMVs)携带紧密黏附素C端结构域(Int280)的新型疫苗,采用PelB信号肽和Lpp-OmpA杂合蛋白两种展示系统分别将Int280定位于囊泡腔内和表面。在小鼠模型中,腹腔接种1 μg OMV-Int280混合物(间隔两周)可诱导强抗紧密黏附素IgG应答,并缩短鼠柠檬酸杆菌粪便排菌持续时间,从第14天(q < 0.0001)至第18天(q = 0.0068)显著减少定植。该疫苗有望用于控制反刍动物中肠出血性大肠杆菌的肠道携带和粪便排菌。
要点
- OMV-Int280疫苗通过PelB和Lpp-OmpA系统分别展示腔内和表面Int280,点印迹和FAS试验证实融合蛋白定位与功能。
- 小鼠腹腔接种1 μg OMV-Int280混合物(间隔两周)诱导强抗紧密黏附素IgG应答。
- 免疫小鼠较未接种对照组鼠柠檬酸杆菌粪便排菌持续时间缩短,第14天(q < 0.0001)至第18天(q = 0.0068)定植显著减少。
核心结论
- OMV-Int280疫苗是控制反刍动物肠出血性大肠杆菌肠道携带和粪便排菌的有前景候选疫苗。
研究设计与样本
- 研究开发基于外膜囊泡(OMVs)携带紧密黏附素C端结构域(Int280)的疫苗,采用PelB信号肽和Lpp-OmpA杂合蛋白两种展示系统。
- 以鼠柠檬酸杆菌小鼠模型进行概念验证,小鼠腹腔接种1 μg OMV-Int280混合物,间隔两周。
主要发现
- 点印迹试验结合FAS试验证实融合蛋白正确定位及Lpp-OmpA-Int280功能。
- 免疫小鼠产生强抗紧密黏附素IgG应答。
- 免疫小鼠较未接种对照组鼠柠檬酸杆菌粪便排菌持续时间缩短,第14天(q < 0.0001)至第18天(q = 0.0068)定植显著减少。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Enterohemorrhagic Escherichia coli (EHEC) are foodborne pathogens causing severe human infections including hemorrhagic colitis and hemolytic uremic syndrome, particularly in children. Ruminants are the main reservoir of EHEC which colonize their intestinal tract through a mechanism involving the bacterial adhesin intimin. Vaccination of cattle has shown efficacy in reducing EHEC O157:H7 shedding in feces. However, most of these vaccines rely on purified proteins and/or adjuvants, making them expensive and not used by breeders. This study introduced the development of a new type of vaccine based on Outer Membrane Vesicles (OMVs) carrying the C-terminal domain of intimin (Int280). A vaccine which combines OMVs carrying luminal Int280 and OMVs displaying surface-exposed Int280 was produced using two addressing systems based on PelB peptide signal and Lpp-OmpA hybrid protein, respectively. Dot blot experiments on OMVs combined with FAS assay with bacteria confirmed the correct localization of the fusion proteins and the functionality of Lpp-OmpA-Int280, respectively. As a proof of concept, the efficiency of the mixed vaccine was tested in a mouse model using the pathogen Citrobacter rodentium which shares a similar intimin-based adhesion mechanism with EHEC. Intraperitoneal vaccination of mice, at two-week intervals with 1 μg of the mixture of OMV-Int280, elicited a strong anti-intimin IgG response. Interestingly, we observed a shortened C. rodentium fecal shedding duration in immunized mice compared to the control unvaccinated group, with significant reduction of C. rodentium colonization from day 14 (q < 0.0001) to day 18 (q = 0.0068). This OMV-Int280 vaccine therefore represents a promising candidate for the control of EHEC intestinal carriage and fecal shedding in ruminants.
引用
- Garling A, Goursat C, Seguy C, et al. Development of intimin-enriched outer membrane vesicles (OMVs) as a vaccine to control intestinal carriage of Enterohemorrhagic Escherichia coli. Vaccine. 2025. PMID: 39985970. doi:10.1016/j.vaccine.2025.126899
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。